Diabetes, Heart and Cardiovascular Diseases News Chronicle. Diabetes, Cardiovascular and Heart Diseases. Article 102
Published on December 28, 2016 at 09:30 PM


 



Diabetes Awareness Campaign

A survey conducted by Boehringer Ingelheim and Eli Lilly & Co found that 75 percent of the Americans and 66 percent of type 2 diabetes (T2D) patients don't know heart disease tops the killer diseases list for type 2 diabetes patients. Both companies started an awareness campaign to educate people about the link between type 2 diabetes and heart disease. The objective of the campaign is to educate people to know about their risk and encourage them to speak with the healthcare provider. Paul Fonteyne, president of Boehringer Ingelheim says cardiovascular disease tops the list of killer diseases for type 2 diabetes (T2D) patients. T2D patients should understand health risks (such as stroke, heart attack or death) and take steps to reduce risks. Mike Mason, Vice President of Eli Lilly & Co says the risk of cardiovascular disease for type 2 diabetes individuals are two to four times higher compared with normal individuals.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. About Meizus H1 Wearable Device
2. Wearable Devices Market
3. Wearable Device To Alleviate Stress and Anxiety
4. Wearable Belt Type Medical Device To Treat Diabetes In Obese Individuals
5. Body Fat Storage

Boehringer Ingelheim : Boehringer Ingelheim is a German based company founded in 1885 by Albert Boehringer. The company manufactures products for the treatment of

  • Central nervous system diseases
  • Immunology
  • Metabolism
  • Respiratory diseases
  • Oncology

The company is involved in collaborative researches and operates globally.

Eli Lilly : Eli Lilly, is a United States based company founded in 1876 by Colonel Eli Lilly. This is the first company to mass-produce penicillin, insulin and Salk polio vaccine. The company manufactures products for the treatment of

  • Bone Muscle Joint
  • Cardiovascular diseases
  • Diabetes
  • Endocrine
  • Immunology
  • Men's Health
  • Neuroscience
  • Oncology

The company markets its products in 125 countries.

 



Risks With Prediabetes

A meta-analysis study done by Chinese researchers shows blood sugar levels recommended by ADA (the year 2003) should be lowered to diagnose prediabetes condition in an individual. Individuals in prediabetes condition under current guidelines are at increased risk of cardiovascular disease and all-cause mortality. Prior lifestyle changes in prediabetes patients may reduce above risks. Researchers analyzed 53 studies containing information on 1.6 million patients. Researchers say 36.2 percent of adults in the US and 50.1 percent of adults in China were in prediabetes condition. Researchers say lifestyle modification is very effective in reducing risks associated with prediabetes condition. The study findings were published in BMJ.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. Tips To Manage Prediabetes Or Diabetes
2. Chameleon Wearable Fitness Tracker From Adidas
3. Access Crosby Wearable Fitness Tracking Products From Michael Kors
4. Portable Device To Check Diabetes With Exhale Of Acetone Chemical
5. Personalized Diet And Fitness Device & App From STYR Labs

 



Blood Pressure Damages Kidney

A long-term study done by researchers from UCSF Medical Center, San Francisco shows type 1 diabetes individuals can reduce the risk of long-term kidney damage with strict blood pressure control. According to the National Kidney Foundation, Kidney disease will be developed in

  • 30 percent of type 1 diabetes (T1D) patients
  • 10 to 40 percent of type 2 diabetes (T2D) patients

The Diabetes Control and Complications Trial (DCCT) study started in the year 1983. In this study, researchers compared blood pressure levels and kidney health type 1 diabetes (T1D) patients. Results show an individual who maintained lower levels of blood pressure continuously were at lower the risk of the development of chronic kidney disease. Lead author of the study is Elaine Ku MD and senior author of the study is Chi-Yuan Hsu MD. The study findings were published in Diabetes Care.



       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below):

Also related to this story
1. Risks With Blood Pressure And High Sugar Levels During Pregnancy
2. Triglycerides, Hypertension, Hypotension & Blood Pressure And Benefits With Intensive Diabetes Treatment
3. Chronic Kidney Disease, Heart Disease & Diabetes Prevention Drugs From Forxiga Drug Maker AstraZeneca
4. Risks With Chronic Kidney Disease CKD
5. Wearable Technology For Elder Care

DCCT : The Diabetes Control and Complications Trial (DCCT) is a random clinical study conducted at multiple centers to determine intensive control directed in maintaining blood sugar levels within normal range will affect the onset or progression of microvascular and neurologic complications in patients with insulin dependent diabetes mellitus (T1D). Total of 1,441 individuals aged between 13 and 39 years participated in this study. The study was conducted at 29 medical centers between 1983 and 1993. This study was conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). According to the American Diabetes Association (ADA), tight diabetes control means maintaining following levels

  • Blood sugar levels before meals : Between 70 and 130 mg/dL
  • Blood sugar levels two hours after meals : Less than 180 mg/dL
  • Keeping glycated hemoglobin (A1c) level at or less than 7 percent

 



Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.